Faculty Bibliography
Searched for:
in-biosketch:true
person:tanejs01
Total Results:
834
Reply by Authors
PMID: 32175794
ISSN: 1527-3792
CID: 4352392
Re: Comparison of Targeted vs Systematic Prostate Biopsy in Men Who Are Biopsy Naive: The Prospective Assessment of Image Registration in the Diagnosis of Prostate Cancer (PAIREDCAP) Study
PMID: 32073966
ISSN: 1527-3792
CID: 4312322
Re: Long Term Follow-up and Outcomes of Re-Treatment in an Expanded 50 Patient Single-Center Phase II Prospective Trial of Lutetium-177 (177Lu) PSMA-617 Theranostics in Metastatic Castrate-Resistant Prostate Cancer
PMID: 32073970
ISSN: 1527-3792
CID: 4312332
Re: Ten-Year Mortality, Disease Progression, and Treatment-Related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received
PMID: 32073978
ISSN: 1527-3792
CID: 4312342
Re: 18F-Fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in Patients with Early Biochemical Recurrence after Prostatectomy: A Prospective, Single-Centre, Single-Arm, Comparative Imaging Trial
PMID: 31928460
ISSN: 1527-3792
CID: 4262912
Re: Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer
PMID: 31928459
ISSN: 1527-3792
CID: 4262902
Re: Risk of Prostate Cancer for Men Fathering through Assisted Reproduction: Nationwide Population Based Register Study
PMID: 31928461
ISSN: 1527-3792
CID: 4262922
Multiparametric MRI for prostate cancer diagnosis: current status and future directions
The current diagnostic pathway for prostate cancer has resulted in overdiagnosis and consequent overtreatment as well as underdiagnosis and missed diagnoses in many men. Multiparametric MRI (mpMRI) of the prostate has been identified as a test that could mitigate these diagnostic errors. The performance of mpMRI can vary depending on the population being studied, the execution of the MRI itself, the experience of the radiologist, whether additional biomarkers are considered and whether mpMRI-targeted biopsy is carried out alone or in addition to systematic biopsy. A number of challenges to implementation remain, such as ensuring high-quality execution and reporting of mpMRI and ensuring that this diagnostic pathway is cost-effective. Nevertheless, emerging clinical trial data support the adoption of this technology as part of the standard of care for the diagnosis of prostate cancer.
PMID: 31316185
ISSN: 1759-4820
CID: 3977962
Re: Metastasis-Directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-Institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy
PMID: 31829824
ISSN: 1527-3792
CID: 4234782
Re: Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a de Novo Low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer
PMID: 31829821
ISSN: 1527-3792
CID: 4234762
